title: Pichia anomala fungaemia in immunocompromised children.
abstract: Pichia anomala is an emerging yeast causing serious nosocomial infections in newborn and immunocompromised children. We describe nosocomial port catheter infection due to P. anomala in three children who were receiving cancer chemotherapy, bloodstream infection in a preterm infant and in an infant with severe combined immunodeficiency. All patients were treated with amphotericin B. All isolates were susceptible to amphotericin B and fluconazole. No recurrence was observed during follow-up in four of five patients. The common clinical feature in all of our patients was the presence of prior antimicrobial therapy.
authors.affiliation: Department of Pediatrics, Marmara University School of Medicine, Istanbul, Turkey. bakirm@superonline.com
authors.forename: M
authors.initials: M
authors.lastname: Bakir
authors.forename: N
authors.initials: N
authors.lastname: Cerikcioğlu
authors.forename: A
authors.initials: A
authors.lastname: Tirtir
authors.forename: S
authors.initials: S
authors.lastname: Berrak
authors.forename: E
authors.initials: E
authors.lastname: Ozek
authors.forename: C
authors.initials: C
authors.lastname: Canpolat
mesh_terms: D000293:Adolescent; D000935:Antifungal Agents / Q000627:therapeutic use; D002648:Child; D005260:Female; D015725:Fluconazole / Q000627:therapeutic use; D016469:Fungemia / Q000188:drug therapy / Q000382:microbiology*; D006801:Humans; D016867:Immunocompromised Host; D007223:Infant; D007231:Infant, Newborn; D008297:Male; D010843:Pichia / Q000187:drug effects / Q000302:isolation & purification*
chemical_list: D000935:Antifungal Agents; D015725:Fluconazole